期刊论文

Qu, Shunlin

英文

Clinica Chimica Acta

0009-8981

2019

495

29-34

10.1016/j.cca.2019.03.1626

We thank our colleagues in Professor Qu's group for technical assistance and stimulating discussions during the review. The authors declare that they have no competing interests. All the authors agree. This work was supported by grants from the National Natural Science Foundation of China (81670424), the Key Scientific Research Fund of Hunan Provincial Education Department (15A166), the Scientific Research Fund of Hunan Provincial Health and Family Planning Commission (B2016087); the National Natural Science Foundation of Hunan Province (2015JJ2118, 2019JJ40258 and 2019JJ50502); the Aid Programme for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province (2008-244); the Construct Programme of the Key Discipline in Hunan Province (2011-76); the Postgraduate Innovation Project of Scientific Research of University of South China (2015XCX38) and the project of “Research Study and Innovative Experiment Program for College Students” in University of South China (2017XJXZ031, 2017XJYZ048 and 2018XJXZ375).

本校为第一且通讯机构

Farnesoid X receptor (FXR) is a transcription factor that can be activated by bile acid as well as influenced bile acid metabolism. β-cell bile acid metabolism is mediated by FXR and closely related to the regulation of blood glucose (BG). FXR can regulate BG through multiple pathways. This review summarises recent studies on FXR regulation of BG balance via bile acid regulation, lowering glucagon-like peptide-1 (GLP-1), inhibiting gluconeogenesis, increasing insulin secretion and enhancing insulin sensitivity. In addition, the current review ...